Mirna Therapeutics microRNAs master regulators of disease
ABOUT MIRNA
 
Mirna is a clinical-stage biopharmaceutical company developing a broad pipeline of leading microRNA-based oncology therapeutics, the first to be tested in cancer patients.
 
 LEARN MORE ABOUT US  >
CLINICAL TRIALS
 
MRX34, Mirna’s lead product candidate, is the first microRNA mimic to enter clinical testing.

LEARN MORE ABOUT OUR CLINICAL TRIALS AND PIPELINE  >
© 2014 Mirna Therapeutics, Inc. All Rights Reserved.